Suchergebnisse - "Buti, Maria"

PubPharm (209)

191

Glecaprevir/pibrentasvir for 8 weeks in treatment-naïve patients with chronic HCV genotypes 1-6 and compensated cirrhosis : The EXPEDITION-8 trial

enthalten in: Journal of hepatology | 2020

von Brown, R. | Buti, M. | Rodrigues, L. | +19

CommentIn: J Hepatol. 2020 Mar;72(3):389-390. - PMID 31703944

192

An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders

enthalten in: Scientific reports | 2020

von Riveiro-Barciela, M. | Gubern, P. | Roade, L. | +6

193

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

enthalten in: Antiviral research | 2020

von Chen, Q. | Perales, C. | Soria, M. | +98

194

Optimal management of chronic hepatitis B patients receiving nucleos(t)ide analogues

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2020

von Buti, M. | Roade, L. | Riveiro-Barciela, M. | +1

195

Role of Biomarkers in Guiding Cure of Viral Hepatitis B

enthalten in: Seminars in liver disease | 2020

von Buti, M. | Riveiro-Barciela, M. | Rodríguez-Frías, F. | +2

196

Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients

enthalten in: Medicine | 2020

von Álvarez-López, P. | Riveiro-Barciela, M. | Oleas-Vega, D. | +7

197

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

enthalten in: Hepatology communications | 2020

von Lok, A. | Zoulim, F. | Dusheiko, G. | +10

198

COVID-19 and hepatitis B infection

enthalten in: Antiviral therapy | 2020

von Alqahtani, S. | Buti, M.

199

Principles for implementing a population screening strategy for hepatitis C in Spain

enthalten in: Revista espanola de enfermedades digestivas | 2020

von Cabezas, J. | García, F. | Calleja Panero, J. | +5

200

Long-term clinical outcomes in patients with chronic hepatitis delta : the role of persistent viraemia

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Palom, A. | Rodríguez-Tajes, S. | Navascués, C. | +6

CommentIn: Aliment Pharmacol Ther. 2020 Jan;51(1):172-173. - PMID 31850558